Personalized Medicine Partnering Terms and Agreements Comprehensive Study

1
Personalized Medicine Partnering Terms and
Agreements
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.

• Published April 2014
• Single User PDF US 3295
• Corporate User PDF US 16495

2
Personalized Medicine Partnering Terms and
Agreements

• "Comprehensive understanding and unprecedented
  access tithe personalized medicine partnering
  deals and agreements entered in by the worlds
  leading healthcare companies.
• The Personalized Medicine Partnering Terms and
  Agreements report provides comprehensive
  understanding and unprecedented access tithe
  personalized medicine partnering deals and
  agreements entered in by the worlds leading
  healthcare companies.
• The report provides a detailed understanding and
  analysis of how and why companies enter
  personalized medicine partnering deals. The
  majority of deals are discovery or development
  stage whereby the licensee obtains a right or an
  option right licenses the licensors personalized
  medicine technology. These deals tend tube
  multicomponent, starting with collaborative RD,
  and commercialization of outcomes.

Follow the link to View Full Report with Table of
Content
3
Personalized Medicine Partnering Terms and
Agreements

• Chapter 1 provides an introduction to the report,
  whilst
• chapter 2 provides an overview of the trends in
  personalized medicine deal making since 2009,
  including details of average headline, upfront,
  milestone and royalty terms.
• Chapter 3 provides a review of the leading
  biomarker deals since 2009. Deals are listed by
  headline value, signed by big pharma and most
  active of all biopharma companies. Where the deal
  has an agreement contract published at the SEC a
  link provides online access to the contract.
• Chapter 4 provides a review of the leading
  companion diagnostic deals since 2009. Deals are
  listed by headline value, signed by bigpharma and
  most active of all biopharma companies. Where the
  deal has an agreement contract published at the
  SEC a link provides online access to the contract.

Get a Sample of the Report _at_ http//www.reportsnre
ports.com/contacts/RequestSample.aspx?name148935
.
4
Personalized Medicine Partnering Terms and
Agreements

• Chapter 5 provides a review of the leading
  pharmacogenomics deals since 2009. Deals are
  listed by headline value. Where the deal has an
  agreement contract published at the SEC a link
  provides online access to the contract.
• Chapter 6 provides a comprehensive listing of the
  top 50 big pharma companies with a brief summary
  followed by a comprehensive listing of
  personalized medicine deals including biomarker,
  companion diagnostic, pharmacogenomics, as well
  as contract documents available in the public
  domain. Where available, each deal title links
  via Web link tan online version of the actual
  contract document, providing easy access teach
  contract document on demand.
• Chapter 7 provides a comprehensive and detailed
  review of biomarker partnering deals signed and
  announced since 2009, where a contract document
  is available in the public domain. The chapter is
  organized by stage of development at signing,
  deal type (collaborative RD, co-promotion,
  licensing etc), and specific therapy focus. Each
  deal title links via Web link tan online version
  of the deal record and where available, the
  contract document, providing easy access teach
  contract document on demand.

Get Discount on the Report _at_ http//www.reportsnre
ports.com/contacts/Discount.aspx?name148935 .
5
Personalized Medicine Partnering Terms and
Agreements

• Chapter 8 provides a comprehensive and detailed
  review of companion diagnostics partnering deals
  signed and announced since 2009, where a contract
  document is available in the public domain. The
  chapter is organized by stage of development at
  signing, deal type (collaborative RD,
  co-promotion, licensing etc), and specific
  therapy focus. Each deal title links via Web link
  tan online version of the deal record and where
  available, the contract document, providing easy
  access teach contract document on demand.
• Chapter 9 provides a comprehensive and detailed
  review of pharmacogenomics partnering deals
  signed and announced since 2009, where a contract
  document is available in the public domain. The
  chapter is organized by stage of development at
  signing, deal type (collaborative RD,
  co-promotion, licensing etc), and specific
  therapy focus. Each deal title links via Web link
  tan online version of the deal record and where
  available, the contract document, providing easy
  access teach contract document on demand.

Get a Sample of the Report _at_ http//www.reportsnre
ports.com/contacts/RequestSample.aspx?name148935
.
6
Personalized Medicine Partnering Terms and
Agreements

• Chapter 8 provides a comprehensive and detailed
  review of companion diagnostics partnering deals
  signed and announced since 2009, where a contract
  document is available in the public domain. The
  chapter is organized by stage of development at
  signing, deal type (collaborative RD,
  co-promotion, licensing etc), and specific
  therapy focus. Each deal title links via Web link
  tan online version of the deal record and where
  available, the contract document, providing easy
  access teach contract document on demand
• Chapter 9 provides a comprehensive and detailed
  review of pharmacogenomics partnering deals
  signed and announced since 2009, where a contract
  document is available in the public domain. The
  chapter is organized by stage of development at
  signing, deal type (collaborative RD,
  co-promotion, licensing etc), and specific
  therapy focus. Each deal title links via Web link
  tan online version of the deal record and where
  available, the contract document, providing easy
  access teach contract document on demand.

Browse more report on Biotechnology
7
Personalized Medicine Partnering Terms and
Agreements

• Chapter 10 provides a comprehensive and detailed
  review of personalized medicine partnering deals
  signed and announced since January 2009. The
  chapter is organized by specific personalized
  medicine, biomarkers, companion diagnostics and
  pharmacogenomics technology type in focus. Each
  deal title links via Web link tan online version
  of the deal record and where available, the
  contract document, providing easy access teach
  contract document on demand.
• In addition, a comprehensive appendix is provided
  organized by personalized medicine partnering
  company A-Z , deal type, and therapy type. Each
  deal title links via Web link tan online version
  of the deal record and where available, the
  contract document, providing easy access teach
  contract document on demand.
• Report scope
• Personalized Medicine Partnering Terms and
  Agreements is intended to provide the reader with
  an in-depth understanding and access personalized
  medicine trends and structure of deals entered in
  by leading companies worldwide.

Get Discount on the Report _at_ http//www.reportsnre
ports.com/contacts/Discount.aspx?name148935 .
8
Personalized Medicine Partnering Terms and
Agreements

• Personalized Medicine Partnering Terms and
  Agreements includes
• Trends in personalized medicine deal making in
  the biopharma industry since 2009
• Analysis of personalized medicine deal structure
• Access headline, upfront, milestone and royalty
  data and contract documents
• Case studies of real-life personalized medicine
  deals
• Access over 1000 personalized medicine deal
  announcements
• The leading personalized medicine deals by value
  since 2009
• Most active personalized medicine dealmakers
  since 2007

Browse more report on Biotechnology
9
Personalized Medicine Partnering Terms and
Agreements

• The leading personalized medicine partnering
  resources In Personalized Medicine Partnering
  Terms and Agreements, the available contracts are
  listed by
• Company A-Z
• Headline value
• Stage of development at signing
• Deal component type
• Specific therapy target
• Follow the link to View Full Report with Table of
  Content

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
10
Personalized Medicine Partnering Terms and
Agreements

• "Personalized Medicine Partnering Terms and
  Agreements provides the reader with the following
  key benefits
• In-depth understanding of personalized medicine
  deal trends since 2009
• Access the deadline, upfront, milestone and
  royalty data
• Analysis of the structure of personalized
  medicine agreements with numerous real life case
  studies
• Comprehensive access over 1000 actual
  personalized medicine deals entered in by the
  worlds bio pharma companies
• Detailed access tactual personalized medicine
  contracts enter in by the leading fifty big
  pharma companies
• Insight in the terms included in a personalized
  medicine agreement, together with real world
  clause examples
• Understand the key deal terms companies have
  agreed in previous deals
• Undertake due diligence tassels suitability of
  your proposed deal terms for partner companies

Get a Sample of the Report _at_ http//www.reportsnre
ports.com/contacts/RequestSample.aspx?name148935
.